The newest weight loss drug on the market, Zepbound, might also help keep peoples snoring down.
The potential benefits of these medications areexpanding well beyond weight loss, however.
The findings have yet to be published in a peer-reviewed journal, so they merit added caution for now.
A Zepbound injection pen from Eli Lilly.Image: oleschwander (Shutterstock)
The company plans to submit its data for approval to the FDA and other regulators by mid-year.
OSA impacts 80 million adults in the U.S., with more than 20 million living with moderate-to-severe OSA.
News from the future, delivered to your present.
Does Ozempic Burn Fat or Just Reduce Appetite?
